Convert VitaStem VITASTEM to edgeX EDGEX

VitaSTEM — The first AI-enabled longevity project and inaugural IP-Token launched by Aubrai, VitaDAO’s decentralized scientific agent. After six months of deep research on public and proprietary single-cell RNA-seq and multi-omics datasets, our scientific research team analyzed more than 850,000 human hematopoietic stem cell transcriptomes from donors aged 23–91 (both male and female). This effort uncovered 100+ high-potential rejuvenation target genes and revealed critical drivers of decline such as RhoA hyperactivation, CD38 upregulation, and CCR9 downregulation. Rather than treating HSC aging as a single defect, Aubrai recognized it as convergent damage across interconnected systems, generating a comprehensive multi-modal, five-phase rejuvenation protocol targeting transcriptional stress, metabolic dysfunction, and epigenetic drift in parallel. The agent shortlisted target genes using insights from thousands of peer-reviewed publications and private data and also optimized experimental protocols to guide in vitro and upcoming pre-clinical testing. For the first time, human researchers and AI Agents collaborate as co-scientists in the creation of pioneering scientific IP.

EdgeX is a decentralized perpetual futures exchange that combines the speed and performance of centralized exchanges with the transparency and self-custody of DeFi. The platform features an off-chain order matching engine with on-chain settlement, enabling high-speed, low-latency trading across a wide range of crypto assets.  Due to a ticker collision, Coinbase will use the ticker "EDGEX" for this asset instead of its on-chain or MiCA whitepaper designation "EDGE". This adjustment ensures compatibility with existing assets on our platform and avoids potential conflicts. The change does not affect the underlying asset's functionality or value.